Methylene blue for treatment of hospitalized COVID-19 patients: a randomized, controlled, open-label clinical trial, phase 2
Hamidi-Alamdari et al., Clinical and Translational Investigation, doi:10.24875/RIC.21000028
https://c19early.org/hamidialamdari.html